Pharmaceuticals, Biotechnology and Life Sciences
Pfizer and BioNTech on Tuesday said they have executed a Material Transfer and Collaboration Agreement to enable the parties to immediately start working together on a potential mRNA-based coronavirus vaccine for preventing COVID-19 infection.
Compassionate care protocol to be conducted at Rambam Healthcare Campus in coordination with the Government of Israel Corona-Virus (COVID-19) death…
Companies will jointly develop BioNTech’s mRNA-based vaccine candidate BNT162 to prevent COVID-19 infection Collaboration aims to accelerate global development of…
NORTHBROOK, Ill.–(BUSINESS WIRE)–A quantitative survey conducted by Continuum Clinical late last week indicates as many as one third of clinical…
HOUSTON–(BUSINESS WIRE)–Celltex Therapeutics Corporation (“Celltex”), a Houston, Texas-based biotechnology company founded in 2011 and focused on spearheading breakthroughs in regenerative…
Clinical trial results in Acute Respiratory Distress Syndrome (ARDS) supported Fast Track designation by FDA and designation by the Biomedical…
HAYWARD, Calif.–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company, today announced financial results for the fourth quarter…
– Steady progress of clinical programs in four indications: MCL, Ewing sarcoma, breast cancer, and CLL – Cirmtuzumab in combination…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–AVEO Oncology (NASDAQ: AVEO) today reported financial results for the full year ended December 31, 2019 and provided…
DUBLIN–(BUSINESS WIRE)–The “Lutetium-177 Market and Pipeline Analysis-Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering. This report gives comprehensive…